 |
|
 |
|
  |
|
 |
|
 |
|
 |
| Syncom and Chemelot Syncom, specialized in contract research in organic synthesis, has opened a new facility on the Chemelot Campus in Geleen (NL). "We help pharmaceutical companies to find the best route to drug compounds. In this specialist area we collaborate with DSM and from our facility at Chemelot this is easier to manage than from our Groningen site," says Syncom general director Ton Vries. Read more: Pressrelease |
Polpharma and Syncom The Fine Chemicals Business Unit of Polpharma the leading Polish Generic Pharma company and Syncom (the Netherlands) have signed series of agreements to use biocatalysis for the synthesis of chiral intermediates and chiral APIs. Polpharma believes it is well equipped to compete in this area, using the expertise of partners like Syncom. Syncom is specialized in the area of Organic Synthesis with emphasis in Chiral Chemistry. Theo Iliopoulos, Vice President of Polpharma and General Manager Fine Chemicals, said: "Polpharma is uniquely positioned for success in the synthesis of APIs using innovative technologies and the cooperation with Syncom enhances our potentials in delivering cost competitive and environmental friendly processes and in reducing the time to market which are key differentiating factors in our success." "Innovation in development methodologies through cooperation and a network of creative forces, is the way forward" he added. Dr. Ton Vries, CEO of Syncom said: "Syncom is delighted with this opportunity to work with Polpharma. Syncom has always been heavily involved in all aspects of chiral chemistry including biocatalysis and we look forward to this opportunity to use our knowledge and expertise in this exciting collaboration."  |
 |
 |
 |
 |  |  |  |  |
| | | |